US Patent Issued to Novartis on May 13 for "Pharmaceutical products and stable liquid compositions of IL-17 antibodies" (Swiss Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,296,008, issued on May 13, was assigned to Novartis AG (Basel, Switzerland).

"Pharmaceutical products and stable liquid compositions of IL-17 antibodies" was invented by Susanne Joerg (Binningen, Switzerland) and Kathrin Serno-Schersch (Basel, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure is directed to pharmaceutical products and stable liquid compositions of IL-17 antibodies and antigen-binding fragments thereof, e.g., AIN457 (secukinumab), and processes of making these pharmaceutical products and compositions. The disclosure is also directed to the use of these pharmaceutical products and liquid compositions (e.g., as part...